Section 1557 of the Affordable Care Act reaches every Medicare program that receives federal financial assistance, and the Biden administration's 2024 final rule makes that reach explicit and enforceable. That includes Medicare Part A hospital coverage, Part B outpatient coverage, Medicare Advantage plans, and Part D drug plans. The rule also applies to Medicare providers who accept federal funds.
Section 1557 has always applied to health programs receiving federal financial assistance. The 2024 final rule clarified exactly which entities fall under that definition and reinstated protections that had been weakened during the Trump administration. For Medicare specifically, the rule confirms that the program's structure of federal payments and contracts triggers nondiscrimination obligations at multiple levels. The result is a comprehensive framework that touches hospitals, physicians, insurers, and the contractors that administer Medicare claims. Entities that ignore these obligations face potential loss of federal funding and enforcement action by the Department of Health and Human Services.
How the funding trigger extends to Medicare
Section 1557 prohibits discrimination on the basis of race, color, national origin, sex, age, or disability in health programs and activities that receive federal financial assistance. The key mechanism is the funding trigger: if an entity receives federal dollars, the nondiscrimination requirements attach to all of its health programs and activities, not just the ones directly funded. This is why the rule's reach into Medicare is broader than it first appears. Medicare payments flow through many channels, and each channel can create coverage obligations.
Medicare Part A, which covers inpatient hospital care and skilled nursing facility care, involves payments from the federal government to hospitals and providers. Those payments constitute federal financial assistance under the rule's interpretation. Hospitals that accept Medicare patients are therefore subject to Section 1557 requirements for all of their operations. This includes language access services for patients with limited English proficiency and auxiliary aids for patients with disabilities.
Medicare Part B, which covers physician services and outpatient care, similarly triggers Section 1557 obligations. Physicians who accept Medicare are recipients of federal funds. The 2024 rule clarifies that this recipient status extends nondiscrimination obligations to the entire practice, not just Medicare-related services. A physician cannot segregate Medicare patients into a separate, unequal track.
Medicare Advantage plans present a more layered picture. These plans are private insurers that contract with Medicare. The 2024 rule treats them as recipients of federal financial assistance because they receive per-member payments from the federal government. This means Medicare Advantage plans must comply with Section 1557's requirements on benefit design, provider network access, and appeals processes. A plan cannot design its network in a way that disproportionately excludes providers serving minority communities, for example.
Medicare Part D prescription drug plans also receive federal subsidies and are therefore covered. Part D sponsors must ensure that their formularies and utilization management tools do not discriminate on protected grounds. The rule specifically addresses the use of clinical algorithms and artificial intelligence in utilization management, requiring that these tools not produce discriminatory outcomes.
Quantified context: the scale of Medicare and enforcement
Medicare covered 67.9 million people in 2023, according to the Centers for Medicare and Medicaid Services. This includes 60.6 million people aged 65 and older and 7.3 million people with disabilities. The program accounted for USD 1.0 trillion in total spending in 2023. These figures illustrate why the rule's application to Medicare has broad practical consequences.
Approximately 50 percent of Medicare beneficiaries were enrolled in Medicare Advantage plans in 2023. That is roughly 32 million people receiving coverage through private plans that now have explicit Section 1557 obligations. The remaining beneficiaries receive coverage through traditional fee-for-service Medicare, where providers accepting Medicare are the covered entities.
HHS received more than 20,000 complaints under Section 1557 between 2016 and 2020, according to data reported by the agency. The 2024 rule strengthens the complaint process and clarifies that individuals can file complaints with the HHS Office for Civil Rights. Enforcement can include voluntary resolution agreements, corrective action plans, and in cases of persistent noncompliance, termination of federal funding.
The 2024 rule also includes specific requirements on language access. Entities must provide language assistance services free of charge and in a timely manner. For Medicare providers, this means having qualified interpreters available for patients with limited English proficiency. The rule does not specify a fixed number of languages that must be covered, but it requires that entities assess the language needs of their patient populations.
Edge cases: where coverage gets complicated
Several edge cases illustrate how the rule's application to Medicare is not always straightforward. Understanding these cases helps providers and plans determine their obligations.
The first edge case involves providers who accept Medicare but not Medicaid. Because Medicare itself is a federal program, accepting Medicare is sufficient to trigger Section 1557 obligations. A provider cannot claim exemption by arguing that they do not accept federal financial assistance directly, because Medicare payments flow from the federal government.
The second edge case involves Medicare Supplemental Insurance, also known as Medigap. These policies are sold by private insurers to supplement traditional Medicare. Medigap policies are not directly funded by the federal government, so they may not be covered entities under Section 1557 unless the insurer also offers Medicare Advantage or Part D plans. This creates a gap: a beneficiary who experiences discrimination in a Medigap plan may not have a Section 1557 remedy unless the insurer has other federal contracts.
The third edge case involves Medicare Administrative Contractors, the private companies that process Medicare claims. These contractors receive federal funds and are covered entities. Their obligations include ensuring that claims processing does not produce discriminatory outcomes. The rule does not specify exactly how contractors should audit their algorithms, but it requires that they not use tools that result in discrimination.
A counterintuitive detail: the 2024 rule explicitly addresses discrimination based on sexual orientation and gender identity as forms of sex discrimination. This means Medicare providers and plans cannot deny coverage or services based on these characteristics. A Medicare Advantage plan that excludes gender-affirming care from its benefit package may face enforcement action under the rule. This is a significant shift from the prior regulatory posture, which had narrowed the definition of sex discrimination.
Timeline of the rule's development and compliance
| Date | Event |
|---|---|
| 2010 | Affordable Care Act enacted, including Section 1557 |
| 2016 | HHS issues first Section 1557 final rule under Obama administration |
| 2020 | Trump administration finalizes rule narrowing protections |
| 2021 | Biden administration begins review of 2020 rule |
| 2022 | HHS proposes new rule restoring and expanding protections |
| 2024 | Final rule published in Federal Register, effective July 5, 2024 |
| 2024 | Compliance dates staggered: most provisions effective within 60 days |
| 2025 | Language access and notice requirements fully enforceable |
The 2024 rule was published in the Federal Register in April and became effective in July 2024. Some provisions have staggered compliance dates. For example, the requirement to post notices of nondiscrimination and language assistance services in prominent locations was enforceable within 60 days of the effective date. The rule requires covered entities to post notices in the top 15 languages spoken by individuals with limited English proficiency in the relevant state.
Misconceptions about Section 1557 and Medicare
Several common misconceptions affect how providers and beneficiaries understand the rule's application to Medicare. Correcting these misconceptions is essential for compliance and for beneficiaries seeking to assert their rights.
The first misconception is that Section 1557 only applies to health insurance plans, not to providers. In reality, the rule applies to any health program or activity that receives federal financial assistance. This includes hospitals, clinics, physician practices, and other providers that accept Medicare. A hospital that receives Medicare payments cannot discriminate on protected grounds.
The second misconception is that the rule only prohibits intentional discrimination. Section 1557 also prohibits policies or practices that have a disparate impact on protected groups, even if the intent was neutral. A Medicare Advantage plan that uses a utilization management algorithm with a disparate impact on minority enrollees may violate the rule, regardless of intent.
The third misconception is that compliance is optional or low-priority. The rule carries enforcement mechanisms, including the potential loss of federal funding. HHS can also require corrective action plans and monitor compliance over time. For Medicare Advantage plans, noncompliance can affect their contract with CMS.
The fourth misconception is that the rule applies only to new programs. The rule applies to all existing health programs and activities that receive federal funding. Providers and plans must review their current policies and practices to ensure compliance, not just new initiatives.
Comparison table: which Medicare programs are covered
| Medicare program | Covered entity | Funding trigger | Key obligations |
|---|---|---|---|
| Part A hospital coverage | Hospitals, skilled nursing facilities | Medicare payments | Language access, auxiliary aids, nondiscrimination notices |
| Part B outpatient coverage | Physicians, outpatient clinics | Medicare payments | Same as Part A, plus effective communication |
| Medicare Advantage | Private insurers | Per-member payments from CMS | Network adequacy, benefit design, appeals |
| Part D drug plans | Private insurers | Federal subsidies | Formulary design, utilization management |
| Medicare Administrative Contractors | Private claims processors | Federal contracts | Claims processing, algorithm audits |
| Medigap | Private insurers | No direct federal funding | Not covered unless insurer has other federal contracts |
Practical actions: what providers and plans should do
Providers and plans that want to ensure compliance with the 2024 rule should take concrete steps. These actions are not exhaustive, but they address the most common gaps.
Audit your language access services. Ensure you have qualified interpreters available and that patients are informed of their right to free language assistance. Review your nondiscrimination notices. Post them in prominent locations, including on your website, and include the top 15 languages spoken in your state. Assess your clinical algorithms and utilization management tools. Determine whether they produce disparate impacts on protected groups and document your findings. Train staff on Section 1557 requirements. Include training on implicit bias, cultural competence, and the prohibition on discrimination based on sexual orientation and gender identity. Establish a complaint process. Ensure patients can file complaints and that you respond in a timely manner.
Red-flag warnings:
Do not assume that because you accept Medicare, you are automatically compliant. The rule requires affirmative steps to ensure nondiscrimination. Do not rely on family members or untrained staff to interpret for patients with limited English proficiency. The rule requires qualified interpreters. Do not use algorithms or utilization management tools without auditing them for disparate impact. The rule specifically flags these tools as potential sources of discrimination. Do not ignore complaints or assume they will not lead to enforcement. HHS has increased its enforcement activity under the 2024 rule.
Limitations and what the rule does not do
The 2024 rule is a significant expansion of Section 1557 protections, but it has limits. Understanding these limits helps set realistic expectations for what the rule can achieve.
First, the rule does not create a private right of action. Individuals cannot sue directly under Section 1557 for discrimination; they must file complaints with HHS or rely on other legal theories. This limits the ability of individuals to seek damages for discrimination.
Second, the rule does not automatically cover all Medicare-related entities. Medigap insurers, for example, are generally not covered unless they have other federal contracts. Similarly, some Medicare providers who do not accept Medicare assignment may have weaker coverage obligations.
Third, the rule's enforcement depends on HHS resources and priorities. The Office for Civil Rights has limited staff and must prioritize complaints. Enforcement actions can take months or years to resolve.
Fourth, the rule does not specify exact numerical thresholds for compliance. For example, it does not say how many interpreters a provider must have on staff or how quickly language assistance must be provided. These determinations are left to case-by-case assessment.
The 2024 rule represents the most significant expansion of Section 1557 since the provision was enacted. For Medicare beneficiaries, it offers stronger protections against discrimination in hospitals, physician offices, and private plans. For providers and plans, it requires a proactive approach to compliance. The rule is not self-executing; it depends on awareness, resources, and enforcement.
This article is general educational information about federal health nondiscrimination rules, not legal advice or a compliance determination for any specific entity. It does not promise outcomes and does not replace review by a qualified health care attorney or compliance professional familiar with your organization and jurisdiction.